NCT01399957View on ClinicalTrials.gov

Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2015

Conditions
Multiple Sclerosis
Trial Locations (1)

06112

Mandell Center for Multiple Sclerosis at the Mount Sinai Rehabilitation Hospital, Hartford

Sponsors
All Listed Sponsors
collaborator

Brown University

OTHER

collaborator

Acorda Therapeutics

INDUSTRY

lead

Mount Sinai Rehabilitation Hospital

OTHER

NCT01399957 - Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter